Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Addex, Phoenix Mecano, Roche, Vaudoise: Swiss Equities Preview

May 19 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in Zurich. Stock symbols are in parentheses. Share prices are from the last close.

The Swiss Market Index of the biggest and most actively traded companies rose 0.7 percent to 6,470.84. The broader Swiss Performance Index increased 0.6 percent to 5,714.23.

Addex Pharmaceuticals Ltd. (ADXN SW): The drugmaker said Emmanuel le Poul, head of one of its business units, will leave the company. The shares dropped 4.1 percent to 11.80 Swiss francs.

Novartis AG (NOVN VX): The drugmaker’s U.S. pharmaceuticals unit should pay $190 million to $285 million in punitive damages on top of the $3.4 million awarded to a dozen women in a gender bias verdict, a plaintiffs’ lawyer said in court.

Separately, Novartis minimized the risks of its Menveo vaccine in an audio news release, the U.S. Food and Drug Administration said. The stock was unchanged at 53.05 francs.

OC Oerlikon Corp. AG (OERL SW): The textile machinery maker controlled by Russian billionaire Viktor Vekselberg said its capital restructuring plan was approved by 99.78 percent of votes at its annual general shareholders’ meeting yesterday. The company’s rights offering will start on May 25. The shares slipped 0.4 percent to 49.8 francs.

Phoenix Mecano AG (PM SW): The maker of coin-recognition systems for vending machines agreed to acquire full ownership of Lohse GmbH to expand its solar business. The stock gained 0.4 percent to 540 francs.

Roche Holding AG (ROG VX): The world’s biggest maker of cancer drugs and partner Biogen Idec Inc. are no longer developing the experimental medicine ocrelizumab for use in patients with rheumatoid arthritis. Roche shares were unchanged at 163.9 francs.

Schlatter Holding AG (STRN SW): The welding machinery maker’s profitability is coming under pressure from the weak euro against the franc, Finanz & Wirtschaft reported, citing Chief Executive Officer Jost Sigrist in an interview. The stock was little changed at 243.8 francs.

Vaudoise Assurances Holding SA (VAHN SW): The Swiss insurer said shareholders had agreed to add 62 million francs ($54 million) to the company’s special reserve. The stock dropped 2.1 percent to 225.10 francs.

To contact the reporters on this story: Carolyn Bandel in Zurich at; Daniela Silberstein in Zurich at

To contact the editors responsible for this story: Frank Connelly at David Merritt at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.